Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
18.18
-3.06 (-14.41%)
At close: Oct 30, 2026, 4:00 PM EST
18.17
-0.01 (-0.06%)
Pre-market: Nov 2, 2026, 8:01 AM EST
Mineralys Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $56 | Buy | Reiterates | $56 | +208.03% | Oct 23, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $49 | Buy | Maintains | $49 | +169.53% | Oct 12, 2026 |
| UBS | UBS | Hold Initiates $29 | Hold | Initiates | $29 | +59.52% | Oct 11, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $52 | Buy | Reiterates | $52 | +186.03% | Aug 13, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $42 → $40 | Buy | Maintains | $42 → $40 | +120.02% | Aug 12, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $55 | Buy | Maintains | $55 | +202.53% | Aug 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $54 | Buy | Maintains | $54 | +197.03% | Aug 12, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $52 | Buy | Maintains | $52 | +186.03% | May 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.